Search

Nicholas A Magnus

from Bismarck, ND
Get Report
Also known as:
Nick A Magnus
Phone and address:
1343 Prairie View Dr, Bismarck, ND 58501
(701) 301-0398
Related to:
Kelly L Magnus, 37Thomas E Magnus, 68Michelle J Heck, 60Amber D Magnus, 40Tahnee J Stremick, 40Lisa R Stremick, 62Dorothy A Kratovil, 81Trent T Stremick, 63
Connected to:
Alexander C Magnus, 41Beverly A Magnus, 76Elena N Magnus, 48Evan L Magnus, 41Johnny Magnus, 86Keisha S Magnus, 37Kenneth M Magnus, 68Kristin S Magnus, 34Magus Magnus, 57Maria Magnus, 70

Nicholas Magnus Phones & Addresses

  • 1343 Prairie View Dr, Bismarck, ND 58501 (701) 301-0398
  • Indianapolis, IN
  • 1314 18Th St, Williston, ND 58801
  • Pewaukee, WI
  • 2301 14Th Ave W, Williston, ND 58801

Industries

Pharmaceuticals

Resumes

Resumes

Nicholas Magnus Photo 1

Research Advisor At Eli Lilly And Company

View page
Location:
Indianapolis, Indiana Area
Industry:
Pharmaceuticals

Publications

Us Patents

Asymmetric Synthesis Of Amino-Pyrrolidinones

View page
US Patent:
6770763, Aug 3, 2004
Filed:
Mar 14, 2003
Appl. No.:
10/389528
Inventors:
Nicholas A. Magnus - Indianapolis IN
Pasquale N. Confalone - Greenville DE
Scott A. Savage - Yardley PA
Matthew Yates - Lafayette IN
Robert E. Waltermir - Hillsborough NJ
David J. Meloni - Bear DE
Silvio Campagna - Candia NH
Assignee:
Bristol-Myers Squibb Company - Princeton NJ
International Classification:
C07D20704
US Classification:
548550, 548551, 502333, 5462484
Abstract:
A novel process for the asymmetric synthesis of an amino-pyrrolidinone of the type shown below from appropriate pyrrolidinones is described. These compounds are useful as intermediates for MMP and TACE inhibitors.

Potentiators Of Glutamate Receptors

View page
US Patent:
7598423, Oct 6, 2009
Filed:
Nov 15, 2005
Appl. No.:
11/718753
Inventors:
Thomas Daniel Aicher - Superior CO, US
Guillermo S. Cortez - Indianapolis IN, US
Todd Michael Groendyke - Ann Arbor MI, US
Albert Khilevich - Westfield IN, US
James Allen Knobelsdorf - Fishers IN, US
Fredrik Pehr Marmsater - Longmont CO, US
Jeffrey Michael Schkeryantz - Fishers IN, US
Tony Pisal Tang - Longmont CO, US
Nicholas Andrew Magnus - Indianapolis IN, US
Assignee:
Eli Lilly and Company - Indianapolis IN
International Classification:
C07D 239/26
C07D 239/28
C07D 241/10
C07D 401/10
C07D 213/02
C07D 291/04
C07D 271/06
C07D 277/20
C07D 417/10
C07D 333/06
C07D 319/06
C07C 49/76
US Classification:
568331, 549 75, 549 78, 549274, 549495, 549502, 548122, 548132, 548182, 548194, 548206, 548236, 548243, 548247, 548253, 5482632, 5483164, 548544, 5462681, 546340, 544297, 544298, 544335, 544336
Abstract:
This application relates to a substituted hydroxyphenyl ketone compound of formula I, or a pharmaceutically acceptable salt thereof, a pharmaceutical composition thereof and its use in treating migraine.

Processes And Intermediates For The Preparation Of 2-(2,6-Dichlorophenyl)-1-[(1S,3R)-3-(Hydroxymethyl)-5-(3-Hydroxy-3-Methylbutyl)-1-Methyl-3,4-Dihydroisoquinolin-2(1H)-Yl]Ethenone

View page
US Patent:
20220242826, Aug 4, 2022
Filed:
Jun 11, 2020
Appl. No.:
17/620198
Inventors:
- Indianapolis IN, US
Neil John KALLMAN - Indianapolis IN, US
Nicholas Andrew MAGNUS - Carmel IN, US
International Classification:
C07D 217/16
Abstract:
The embodiments of the present invention provide processes and intermediates for the preparation of D1 PAM I: Formula (I).
Control profile
Nicholas A Magnus from Bismarck, ND Get Report